Skip to main content
Fig. 9 | Cancer Cell International

Fig. 9

From: Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5

Fig. 9

Knockdown of circ-SFMBT2 inhibited tumor progression of EC in vivo by regulating miR-107 and SLC1A5. A The circ-SFMBT2 expression was detected using qRT-PCR in TE1 cells of sh-NC or sh-circ-SFMBT2 group. B, C Tumor volume (B) and weight (C) were determined in sh-NC or sh-circ-SFMBT2 group. D, E The qRT-PCR and western blot were used to assay the expression of circ-SFMBT2 or miR-107 (D) and SLC1A5 (E) in tumor tissues. F IHC assay was performed for the protein analysis for SLC1A5, Ki67 and MMP9. **P < 0.01, ***P < 0.001, ****P < 0.0001

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us